PHVS peer analysis
Pharvaris (PHVS) against its competitors: price, today's move, 1-year return and market value side by side.
PHVS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BCRX BioCryst | $7.53 | -1.38% | 6.14% | $1.92B |
| BMRN BioMarin | $57.11 | -0.12% | 10.98% | $11.06B |
| PHAR Pharming Group | $13.16 | 7.08% | -14.71% | $931.44M |
| RLYB Rallybio | $15.66 | -0.57% | 213.05% | $84.31M |
| TVTX Travere Therapeutics | $51.98 | 0.68% | 60.73% | $4.99B |
| VERA Vera Therapeutics | $30.07 | -1.76% | 24.31% | $2.17B |
| PHVS Pharvaris | $34.02 | -1.32% | 57.55% | $2.39B |
- PHVS's peers: BCRX (BioCryst), BMRN (BioMarin), PHAR (Pharming Group), RLYB (Rallybio), TVTX (Travere Therapeutics), VERA (Vera Therapeutics).
Updated 2026-11-11 00:49 UTC